Reuters Health Report: August 1, 2017

Click to View in Browser Tuesday, August 1, 2017 Trump aims at insurers in battle over healthcare subsidies WASHINGTON/NEW YORK (Reuters) - U.S. President Donald Trump took aim at insurers on Monday in an escalating threat to cut the healthcare subsidy payments that make Obamacare plans affordable, after repeatedly urging Republican senators to keep working to undo his Democratic predecessor's healthcare law. Philippines has highest HIV infection growth rate in Asia-Pacific: U.N. MANILA (Reuters) - The Philippines has registered the fastest-growing HIV/AIDS epidemic in the Asia-Pacific in the past six years with a 140-percent increase in the number of new infections, the health ministry and the United Nations said on Tuesday. AstraZeneca gets breakthrough status for blood cancer drug LONDON (Reuters) - AstraZeneca said on Tuesday that U.S. regulators had awarded its blood cancer drug acalabrutinib "breakthrough" status for the treatment of patients with mantle cell lymphoma, a rare type of blood cancer. Express Scripts to cover Mylan's EpiPen, exclude rivals NEW YORK (Reuters) - Pharmacy benefit manager Express Scripts Holding Co said on Monday it would favor drugmaker Mylan Inc's versions of the EpiPen lifesaving allergy treatment over the allergy auto-injectors of other companies. AstraZeneca fights back in cancer with new hires, fast drug status LONDON (Reuters) - AstraZeneca hired two senior scientists to bolster its cancer drug work on Monday, signaling confidence in its oncology portfolio despite last week's big setback in a lung cancer clinical trial. J&J arthritis drug sirukumab raises safety concerns: FDA staff (Reuters) - There were more deaths in patients taking Johnson & Johnson's experimental rheumatoid arthritis drug sirukumab than among those taking a placebo, staff reviewers for the U.S. Food and Drug Administration said in a report published Monday. Being born in U.S. 'stroke belt' tied to higher risk of dementia (Reuters Health) - Hailing from the so-called stroke belt, a band of southern U.S. states with high stroke mortality rates, is associated with increased odds of developing dementia, even for people who relocate, a new study suggests. More than a third of U.S. adults prescribed opioids in 2015 (Reuters Health) - The United States needs to curb excessive opioid prescribing and improve access to pain management techniques, suggests a new government study. Scientists develop scorpion 'milking machine' for disease research CASABLANCA, Morocco (Reuters) - Extracting venom from scorpions can be a dangerous, but rewarding, task. Molecular profile hints at inflammatory processes in chronic fatigue (Reuters Health) - - People with severe symptoms of chronic fatigue syndrome have a molecular signature in their blood made up of 17 immune system signaling molecules that are elevated, which may provide insight into how inflammation contributes to the mysterious condition. Related Video Engineering an end to climate change UK zoo donates white rhino eggs in IVF effort A quick-fix on the day's news delivered when you want it. Register Today A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today » » MORE NEWSLETTERS - 3 Times Square New York, NY 10036 USA © Copyright 2017 Thomson Reuters Ensure delivery of Reuters Newsmails, add newsletters@email.reuters.com to your address book. Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook